Brief: ImmuCell Corporation Q2 EPS USD 0.2
13/08/2026 21:06
BRIEF-ImmuCell Corporation Q2 EPS USD 0.2 Aug 13 (Reuters) - ImmuCell Corporation Q2 net income USD 1.835 million.
- Q2 basic EPS USD 0.2
- Q2 operating expenses USD 502 thousand
- Q2 pretax profit USD 1.881 million
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year